Avai Bio (AVAI) Invested Capital (2018 - 2025)
Avai Bio's Invested Capital history spans 7 years, with the latest figure at -$1.5 million for Q1 2024.
- On a quarterly basis, Invested Capital fell 174.5% to -$1.5 million in Q1 2024 year-over-year; TTM through Mar 2024 was -$1.5 million, a 174.5% decrease, with the full-year FY2024 number at -$1.5 million, down 174.5% from a year prior.
- Invested Capital hit -$1.5 million in Q1 2024 for Avai Bio, down from -$1.4 million in the prior quarter.
- Over the last five years, Invested Capital for AVAI hit a ceiling of $80148.0 in Q3 2020 and a floor of -$1.5 million in Q1 2024.
- Historically, Invested Capital has averaged -$503962.1 across 5 years, with a median of -$321653.0 in 2021.
- Biggest five-year swings in Invested Capital: skyrocketed 114.64% in 2020 and later crashed 750.43% in 2021.
- Tracing AVAI's Invested Capital over 5 years: stood at -$304983.0 in 2020, then decreased by 5.09% to -$320492.0 in 2021, then fell by 0.72% to -$322814.0 in 2022, then plummeted by 333.96% to -$1.4 million in 2023, then fell by 4.69% to -$1.5 million in 2024.
- Business Quant data shows Invested Capital for AVAI at -$1.5 million in Q1 2024, -$1.4 million in Q4 2023, and -$892302.0 in Q3 2023.